NCT03492437 2023-08-07Effect of Tepotinib on the PK of the P-gp Substrate Dabigatran EtexilateMerck KGaA, Darmstadt, GermanyPhase 1 Completed20 enrolled 14 charts
NCT01014936 2022-08-24First-in-Man, Dose-escalation Trial of C-met Kinase Inhibitor MSC2156119J in Subjects With Advanced Solid TumorsEMD SeronoPhase 1 Completed149 enrolled 41 charts
NCT01988493 2022-08-24Efficacy, Safety, and Pharmacokinetic of MSC2156119J in Asian Participants With Hepatocellular CarcinomaMerck KGaA, Darmstadt, GermanyPhase 1/2 Completed117 enrolled 30 charts
NCT02115373 2022-08-24c-Met Second-Line Hepatocellular CarcinomaMerck KGaA, Darmstadt, GermanyPhase 1/2 Completed66 enrolled 34 charts